123 related articles for article (PubMed ID: 36379464)
1. [Metabolic syndrome and gastrointestinal cancer screening].
Scherübl H
Z Gastroenterol; 2023 Oct; 61(10):1394-1400. PubMed ID: 36379464
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic syndrome and cancer risk].
Scherübl H
Dtsch Med Wochenschr; 2022 Aug; 147(16):1068-1077. PubMed ID: 35970189
[TBL] [Abstract][Full Text] [Related]
3. [Type-2-diabetes and gastrointestinal cancer screening].
Scherübl H
Z Gastroenterol; 2023 Jun; 61(6):683-689. PubMed ID: 35697066
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data.
Rothwell JA; Jenab M; Karimi M; Truong T; Mahamat-Saleh Y; Ferrari P; Dashti SG; Kühn T; Cross AJ; Severi G; Gunter MJ; Murphy N
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1338-e1352. PubMed ID: 34687971
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
[TBL] [Abstract][Full Text] [Related]
6. Long-term metabolic fate and mortality in obesity without metabolic syndrome.
Käräjämäki AJ; Korkiakoski A; Hukkanen J; Kesäniemi YA; Ukkola O
Ann Med; 2022 Dec; 54(1):1432-1443. PubMed ID: 35594302
[TBL] [Abstract][Full Text] [Related]
7. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
8. Genetic risk, metabolic syndrome, and gastrointestinal cancer risk: A prospective cohort study.
Liu Y; Yan C; Yin S; Wang T; Zhu M; Liu L; Jin G
Cancer Med; 2023 Jan; 12(1):597-605. PubMed ID: 35730595
[TBL] [Abstract][Full Text] [Related]
9. Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention.
Lee SH; Jeong MH; Kim JH; Kim MC; Sim DS; Hong YJ; Ahn Y; Chae SC; Seong IW; Park JS; Chae JK; Hur SH; Cha KS; Kim HS; Gwon HC; Seung KB; Rha SW;
J Cardiol; 2018 Oct; 72(4):328-334. PubMed ID: 29709405
[TBL] [Abstract][Full Text] [Related]
10. Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.
Park B
J Gynecol Oncol; 2022 Jul; 33(4):e35. PubMed ID: 35320886
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and the risk of severe cancer events: a longitudinal study in Japanese workers.
Van Hoang D; Inoue Y; Fukunaga A; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Yamamoto M; Miyamoto T; Gommori N; Kochi T; Shirasaka T; Eguchi M; Ogasawara T; Yamamoto K; Konishi M; Katayama N; Kabe I; Dohi S; Mizoue T
BMC Cancer; 2023 Jun; 23(1):555. PubMed ID: 37328825
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms behind the link between obesity and gastrointestinal cancers.
Tilg H; Moschen AR
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenic obesity in early breast cancer patients with metabolic syndrome: a cross-sectional study.
Bulut G; Atci N
Future Oncol; 2022 Jun; 18(20):2489-2498. PubMed ID: 35543029
[No Abstract] [Full Text] [Related]
15. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
16. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
17. Serum adiponectin, body adiposity and metabolic parameters in obese Egyptian children with Down syndrome.
Yahia S; El-Farahaty R; El-Gilany AH; Shoaib R; Ramadan R; Salem N
J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1401-1410. PubMed ID: 34348423
[TBL] [Abstract][Full Text] [Related]
18. The Intersection of Maternal Metabolic Syndrome, Adverse Pregnancy Outcomes, and Future Metabolic Health for the Mother and Offspring.
Girardi G; Bremer AA
Metab Syndr Relat Disord; 2022 Jun; 20(5):251-254. PubMed ID: 35384734
[TBL] [Abstract][Full Text] [Related]
19. The association of metabolic syndrome status with sensorineural hearing loss in pediatric obese patients.
Ozdemir O; Ucar A; Cakir AD; Misir E; Yigit O
Int J Pediatr Otorhinolaryngol; 2023 Feb; 165():111454. PubMed ID: 36696712
[TBL] [Abstract][Full Text] [Related]
20. Association between childhood obesity and metabolic syndrome: evidence from a large sample of Chinese children and adolescents.
Chen F; Wang Y; Shan X; Cheng H; Hou D; Zhao X; Wang T; Zhao D; Mi J
PLoS One; 2012; 7(10):e47380. PubMed ID: 23082159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
